PAREXEL International Corporation (PRXL) : Taylor Frigon Capital Management scooped up 8,555 additional shares in PAREXEL International Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 21,810 shares of PAREXEL International Corporation which is valued at $1,446,439.PAREXEL International Corporation makes up approximately 1.45% of Taylor Frigon Capital Management’s portfolio.
Other Hedge Funds, Including , Mutual Of America Capital Management boosted its stake in PRXL in the latest quarter, The investment management firm added 18,525 additional shares and now holds a total of 104,924 shares of PAREXEL International Corporation which is valued at $6,958,560. PAREXEL International Corporation makes up approx 0.14% of Mutual Of America Capital Management’s portfolio.Parkside Financial Bank Trust reduced its stake in PRXL by selling 187 shares or 21.85% in the most recent quarter. The Hedge Fund company now holds 669 shares of PRXL which is valued at $44,368. PAREXEL International Corporation makes up approx 0.02% of Parkside Financial Bank Trust’s portfolio.Louisiana State Employees Retirement System reduced its stake in PRXL by selling 800 shares or 5.37% in the most recent quarter. The Hedge Fund company now holds 14,100 shares of PRXL which is valued at $923,691. PAREXEL International Corporation makes up approx 0.05% of Louisiana State Employees Retirement System’s portfolio.New England Research Management boosted its stake in PRXL in the latest quarter, The investment management firm added 3,725 additional shares and now holds a total of 20,911 shares of PAREXEL International Corporation which is valued at $1,315,093. PAREXEL International Corporation makes up approx 1.15% of New England Research Management’s portfolio.
PAREXEL International Corporation closed down -1.11 points or -1.61% at $67.9 with 3,91,315 shares getting traded on Monday. Post opening the session at $68.76, the shares hit an intraday low of $67.76 and an intraday high of $69 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, PAREXEL International Corporation reported $0.94 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.93. The company had revenue of $538.60 million for the quarter, compared to analysts expectations of $532.59 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.
Many Wall Street Analysts have commented on PAREXEL International Corporation. Credit Suisse Initiated PAREXEL International Corporation on Jun 21, 2016 to “Outperform”, Price Target of the shares are set at $75.
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company which provides a range of expertise in clinical research clinical logistics medical communications consulting commercialization and advanced technology products and services to the pharmaceutical biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management data management epidemiology health economics/outcomes research pharmacovigilance medical communications clinical pharmacology patient recruitment clinical supply and drug logistics post-marketing surveillance medical imaging services electronic data capture systems clinical trial management systems Web-based portals and other product development tools and services.